Found: 15
Select item for more details and to access through your institution.
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318765288
- By:
- Publication type:
- Article
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 1, p. 1, doi. 10.1177/2055217318765288
- By:
- Publication type:
- Article
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
- Published in:
- Nature Medicine, 2015, v. 21, n. 7, p. 777, doi. 10.1038/nm.3877
- By:
- Publication type:
- Article
Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 2, p. 219, doi. 10.1164/rccm.201411-2128oc
- By:
- Publication type:
- Article
Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Endothelial Chromosome 13 Deletion in Congenital Heart Disease-associated Pulmonary Arterial Hypertension Dysregulates SMAD9 Signaling.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 7, p. 850, doi. 10.1164/rccm.201411-1985le
- By:
- Publication type:
- Article
Endothelial chromosome-13 deletion in congenital heart disease-associated Pulmonary Arterial Hypertension dysregulates SMAD9 signaling.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 7, p. 1, doi. 10.1164/rccm.201411-1985le
- By:
- Publication type:
- Article
Correction of Nonsense BMPR2 and SMAD9 Mutations by Ataluren in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2013, v. 49, n. 3, p. 403, doi. 10.1165/rcmb.2013-0100OC
- By:
- Publication type:
- Article
Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Altered MicroRNA Processing in Heritable Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 184, n. 12, p. 1400, doi. 10.1164/rccm.201106-1130oc
- By:
- Publication type:
- Article
The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 25, p. 5296, doi. 10.1093/hmg/ddt492
- By:
- Publication type:
- Article
The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 18, p. 3667, doi. 10.1093/hmg/ddt216
- By:
- Publication type:
- Article
Potential PINK1 Founder Effect in Polynesia Causing Early‐Onset Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 9, p. 2199, doi. 10.1002/mds.28665
- By:
- Publication type:
- Article
Genomic stability of pulmonary artery endothelial colony-forming cells in culture.
- Published in:
- Pulmonary Circulation, 2017, v. 7, n. 2, p. 421, doi. 10.1177/2045893217700901
- By:
- Publication type:
- Article